Patrick Heron, Director at Tobira Therapeutics, holds 3.73M shares in Mirum Pharmaceuticals (Ticker: MIRM), holds 4.55M shares in MBX Biosciences, Inc. (Ticker: MBX), holds 18.83K shares in Arcutis Biotherapeutics (Ticker: ARQT). Most recently, Patrick Heron Bought ― shares of Mirum Pharmaceuticals on Sep 20, 2024 for an estimated value of 4.30K.
Patrick Heron latest transaction was an Informative Buy of $4.30K.
What was Patrick Heron's most profitable transaction?
Patrick Heron’s most profitable transaction was an Informative Buy of MIRM stock on November 14, 2023. The return on the trade was 52.50%.
What is Patrick Heron's role in Tobira Therapeutics?
Patrick Heron's role in Tobira Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.